SCHEMBL4685148

SCHEMBL4685148

Cn1nc(-c2ccc(Cl)cc2)cc1C(=N)c1ccsc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
TACR2 P21452 1/20 0.39
TACR1 P25103 1/20 0.39
TACR3 P29371 1/20 0.39
CYP2C19 P33261 1/20 0.39
NPC1 O15118 5/20 0.37
RAB9A P51151 5/20 0.37
KDM4E B2RXH2 2/20 0.37
HPGD P15428 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
LMNA P02545 2/20 0.37
TP53 P04637 1/20 0.37
HSD17B10 Q99714 1/20 0.37
POLB P06746 2/20 0.37
GRM5 P41594 1/20 0.34
CHRNA7 P36544 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4744865 0.84 TOP1 (0.37) MAPTNPC1RAB9ASMN1; SMN2GRM5
SCHEMBL4681353 0.75 MAPT (0.46) MAPTCYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL28014535 0.71 MAPT (0.52) MAPTCYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL2565586 0.71 MAPT (0.56) MAPTCYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL4682439 0.70 MAPT (0.39) MAPTCYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL3103714 0.70 MAPT (0.51) MAPTCYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL14091695 0.68 NPC1 (0.54) MAPTNPC1RAB9AKDM4EHPGD
SCHEMBL11073103 0.68 CYP1A2 (0.53) MAPTCYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL1716280 0.67 MAPT (0.50) MAPTCYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL4682443 0.67 NPC1 (0.50) MAPTCYP1A2CYP2D6CYP2C9NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1513796-B1 PHENYLOXYALKANOIC ACID DERIVATIVES AS HPPAR ACTIVATORS SMITHKLINE BEECHAM CORP (US) 2008-02-13 EP disclosed
US-7241793-B2 Phenyloxyalkanonic acid derivatives as hPPAR activators SMITHKLINE BEECHAM CORPORATION (US) 2007-07-10 US disclosed
US-20050222424-A1 Phenyloxyalkanonic acid derivatives as hppar activators SMITHKLINE BEECHAM CORPORATION 2005-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050222424-A1 Phenyloxyalkanonic acid derivatives as hppar activators CEL, HPN, LIPA MAPT 4374/4885CYP1A2 688/4885CYP3A4 253/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.